SRE vs TERN · P/E 31, rev $13.70B vs $6.12B cap
Sempra Energy (SRE) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
SRE currently screens at market cap $59.76B and trailing P/E 31.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the SRE and TERN stock pages for the full models.
Not investment advice.